Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Immunobiology
|
March 20, 1999
Monomorphic HLA class I-(non-A, non-B) expression on Ewing's tumor cell lines, modulation by TNF-alpha and IFN-gamma
A Borowski, F van Valen, M Ulbrecht, et al.
The Journal of Heart Valve Disease
|
May 1, 1994
Left ventricular geometry and function before and after mitral valve replacement
H J Deutsch, J M Curtius, C Bongarth, et al.
The Thoracic and Cardiovascular Surgeon
|
August 1, 1991
Diagnostic value of transesophageal echocardiography in cardiac surgery
H J Deutsch, J M Curtius, R Leischik, et al.
Cancer
|
November 13, 2014
Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication
Stephanie J Sohl, Laurel A Borowski, Erin E Kent, et al.
Cytotherapy
|
October 30, 2004
Intraoperative isolation and processing of BM-derived stem cells
A Ghodsizad, H-M Klein, A Borowski, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 13, 2008
Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts
A Borowski, M Kuepper, U Horn, et al.
Human Molecular Genetics
|
April 1, 1997
Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene
L A Clarke, C S Russell, S Pownall, et al.
Blood
|
February 3, 1998
Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas
R Siebert, P Matthiesen, S Harder, et al.
Genes & Development
|
June 17, 1998
Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span
C D Helgason, J E Damen, P Rosten, et al.
The Heart Surgery Forum
|
April 1, 2005
Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases
H-M Klein, A Ghodsizad, A Borowski, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Immunobiology
|
March 20, 1999
Monomorphic HLA class I-(non-A, non-B) expression on Ewing's tumor cell lines, modulation by TNF-alpha and IFN-gamma
A Borowski, F van Valen, M Ulbrecht, et al.
The Journal of Heart Valve Disease
|
May 1, 1994
Left ventricular geometry and function before and after mitral valve replacement
H J Deutsch, J M Curtius, C Bongarth, et al.
The Thoracic and Cardiovascular Surgeon
|
August 1, 1991
Diagnostic value of transesophageal echocardiography in cardiac surgery
H J Deutsch, J M Curtius, R Leischik, et al.
Cancer
|
November 13, 2014
Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication
Stephanie J Sohl, Laurel A Borowski, Erin E Kent, et al.
Cytotherapy
|
October 30, 2004
Intraoperative isolation and processing of BM-derived stem cells
A Ghodsizad, H-M Klein, A Borowski, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 13, 2008
Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts
A Borowski, M Kuepper, U Horn, et al.
Human Molecular Genetics
|
April 1, 1997
Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene
L A Clarke, C S Russell, S Pownall, et al.
Blood
|
February 3, 1998
Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas
R Siebert, P Matthiesen, S Harder, et al.
Genes & Development
|
June 17, 1998
Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span
C D Helgason, J E Damen, P Rosten, et al.
The Heart Surgery Forum
|
April 1, 2005
Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases
H-M Klein, A Ghodsizad, A Borowski, et al.
Page
of 6